Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

34.51 -0.70 (-1.99%)
Delayed Quote Updated: 2:59 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Amazon To Rally Over 28%? Here Are 10 Other Analyst Forecasts For Tuesday ↗
Citigroup raised the price target for AT&T Inc. (NYSE: T) from $20 to $22. Citigroup analyst Michael Rollins maintained a Buy rating. AT&T shares fell 1% to $18.91 in pre-market trading. 
Via Benzinga
News headline image
Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
From Omnicell, Inc.
Via Business Wire
News headline image
Why Shares of Omnicell Dropped 33.6% This Week ↗
The healthcare medication management company released lowered guidance. 
Via The Motley Fool
News headline image
Where Omnicell Stands With Analysts ↗
Omnicell (NASDAQ:OMCL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Omnicell ↗
Within the last quarter, Omnicell (NASDAQ:OMCL) has observed the following analyst ratings: 
Via Benzinga
News headline image
Expert Ratings for Omnicell ↗
Omnicell (NASDAQ:OMCL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022 ↗
Upgrades 
Via Benzinga
News headline image
9 Analysts Have This to Say About Omnicell ↗
Over the past 3 months, 9 analysts have published their opinion on Omnicell (NASDAQ:OMCL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
Rogers, Airbnb, Herbalife And Some Other Big Stocks Moving Lower On Wednesday ↗
U.S. stocks traded lower, with the Nasdaq Composite dropping more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
News headline image
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results. 
Via Benzinga
News headline image
Omnicell: Q3 Earnings Insights ↗
Omnicell (NASDAQ:OMCL) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Omnicell beat estimated earnings... 
Via Benzinga
News headline image
Omnicell Announces Financial Results for Third Quarter 2022
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems
From Omnicell, Inc.
Via Business Wire
News headline image
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce ↗
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero... 
Via Benzinga
News headline image
Morgan Stanley To Rally Over 10%? Here Are 5 Other Price Target Changes For Wednesday ↗
Credit Suisse raised the price target on Morgan Stanley (NYSE: MS) from $95 to $97. Credit Suisse analyst Susan Roth Katzke maintained the stock with an Outperform rating. Morgan Stanley shares rose... 
Via Benzinga
News headline image
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day
From Omnicell, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022 ↗
  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Omnicell to Present at the 2022 Wells Fargo Healthcare Conference
From Omnicell, Inc.
Via Business Wire
News headline image
Omnicell to Host Investor Day on September 20, 2022
From Omnicell, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 72 companies set new 52-week lows. 
Via Benzinga
News headline image
Recap: Omnicell Q2 Earnings ↗
Omnicell (NASDAQ:OMCL) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Omnicell missed estimated earnings... 
Via Benzinga
News headline image
Omnicell Announces Financial Results for Second Quarter 2022
From Omnicell, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022 ↗
  
Via Benzinga
News headline image
Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022
From Omnicell, Inc.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.